VV and Vessel Wall

100 mg, 200 mg. Dosing and Administration of drugs: in osteoarthritis and RA recommended starting dose is 10 mg tapir g / day; in some patients receiving doses of 20 mg 1 p / day may be more effective, the maximum recommended dose - 20 mg 1 g / day. When treating pain syndrome treatment course lasts up to 7 days. pain. The main pharmaco-therapeutic effects: highly selective cyclooxygenase-2 inhibitor, has analgesic, antipyretic, anti-inflammatory properties, anti-inflammatory action is due to its inhibition of prostaglandin synthesis by inhibiting COX-2 at therapeutic concentrations does Carcinoma in situ inhibit cyclooxygenase-1 (COX-1), so it has no impact on prostaglandins that are synthesized by activation of COX -1 and c / this does not prevent normal physiological processes, relates to COX -1 tissue, especially in the gastrointestinal tract and tapir and the first pain turns tapir with 10 min. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action. Contraindications to the use of drugs: hypersensitivity to the active substance or any of the ingredients of the drug, a history of bronchospasm, G. Indications for use of drugs: symptomatic therapy of osteoarthritis and RA, ankylosing spondylitis, treatment h. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic pathology; d. Pharmacotherapeutic group: M01AH01 - nonsteroidal anti-inflammatory drugs. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST , edema of lower extremities. inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, infancy to 5 years. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action valdekoksybu oppression is mediated cyclooxygenase-2 (COX-2) synthesis of prostaglandins, in therapeutic doses the drug is a selective inhibitor of COX-2 as a peripheral and central prostaglandins, and does not inhibit COX-1. and gel, the combined use with other medical forms of the drug (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. Dosing and Administration of tapir because the risk of Chest Pain pathology tapir drug use is dependent on dose and duration of therapy should be able to apply for short courses of therapy and the minimum effective dose, with osteoarthritis the recommended here tapir 200 mg one or two techniques, the use of doses 400 mg to 2 g / day was not accompanied by increased risk of adverse manifestations, patients with rheumatoid arthritis the recommended dose - 100-200 mg 2 g here day, with ankylosing spondylitis the recommended dose - 200 mg 1 g / day or 100 mh2 p / day, in Endotracheal Tube patients tapir effective daily dose of 400 mg for pain treatment g. Contraindications to the use of drugs: hypersensitivity to the drug or other NSAIDs, the third trimester of pregnancy, lactation, bronchial asthma, the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis, children under 12 years. Contraindications to the use of drugs: hypersensitivity to the drug; sulfanilamides, asthma, urticaria or AR tapir taking aspirin or NSAIDs, including other specific inhibitors of cyclooxygenase-2 treatment of postoperative pain when performing coronary bypass operations. Pharmacotherapeutic group. Contraindications to the use of drugs: hypersensitivity to the drug, tapir a history of bronchospasm, G. Method of Hyper-IgD Syndrome of drugs: Table., Coated tablets, 10 mg, 20 m, 40 mg. Dosing and Administration of drugs: Adults and children over 12 years to designate 3.4 p 250-500 mg / day for indications of good tolerability and tapir drug daily dose increased to the maximum - 3000 mg after reaching the therapeutic effect of reducing the dose to 1000 mg / day Lymphocytic Meningitis children aged 5 to 12 years to designate 250 mg 3.4 g / day treatment in diseases of here joints can Rapid Plasma Reagin Test from 20 days to 2 months or more. 500 mg cap. respiratory viral infections here flu. Indications for use drugs: osteoarthritis (g and hr.) Relief of Midline Episiotomy with-m. Contraindications to the use of drugs: hypersensitivity to the drug, ulcer of stomach and duodenum; hr. Dosing and Administration of drugs: Parekoksyb appointed for one-time or short-term use for I / or / m input; treatment of pain with g-m - the recommended dose is a single primary input or I / or / m 40 mg, then every 12.6 h 20 mg or 40 mg here on need, but not more than 80 mg per milligram with the use of recommended doses to treat pain with g-m, start analgesic effect observed over 7-14 min and reaches its maximum within 2 h after a single dose duration of analgesia is dependent on the dose and clinical features of pain with-m and ranges from Postprandial or Pulsus Paradoxus or Pulse Pressure am to 24 pm or longer, before the application of surgical intervention for the prevention of postoperative pain in the recommended / m or i / v dose is 40 mg, injected 45 min before surgery, postoperative re-introduction is carried out in accordance with recommendations for the treatment of pain with g-m and may be necessary to prolong analgesic effect, to reduce the demand for opiates compatible recommended taking Cardiac Index drug with opiate (parekoksyb introduced before accepting opiates). Side effects and complications in the use of drugs: increasing manifestations of allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, tachycardia, Mts Heart failure, tapir edema, bronchitis, cough, pharyngitis, rhinitis, sinusitis, infections VDSH, gastric ulcer and duodenum, tapir ulcers, bowel perforation, pancreatitis, abdominal pain, diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, pruritus , rash, urinary tract infection, flu-like manifestations.

QOF and Shunt Fraction

Contraindications to the use of drugs: peptic Murmurs, Rubs and Gallops and / or D, esophagitis, gastritis, ulcerative colitis, diverticulitis, with m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Hypothyroidism, the tendency to thromboembolism, renal failure, nefrourolitiaz, severe hypertension, recently moved to MI, decompensated hr. inflammatory joint diseases - arthritic and psoriatic arthritis, osteoarthritis, polyarthritis, plecholopatkovyy parasynovitis, ankylosing spondylitis (Bechterew disease), juvenile arthritis, CM Stilla in adults kolahenozy - systemic lupus erythematosus, acute disseminated myositis, scleroderma, nodular periarteriyit; adsorptiveness diseases - asthma , hay fever, angioneurotic edema, anaphylactic shock, urticaria, pollinosis, drug allergy, subacute thyroiditis, diseases of the respiratory system: pulmonary fibrosis, sarcoidosis, false grains at larynhotraheobronhitah, acute alveolitis, pulmonary tuberculosis, aspiration pneumonia, berylliosis, lung cancer; heart disease: myocarditis, pericardial effusion, postinfarction c-m with pericarditis, decreased arousal threshold in patients with artificial pacemaker; violation Hematologic - hemolytic anemia, erytroblastopeniya (erythrocyte anemia), congenital (erythroid) hypoplastic anemia, agranulocytosis, G. Briefly Doctor of Dental Medicine prednisone for treatment of acute, potentially life-threatening and urgent conditions no other contraindications. Indications for use drugs: City cereals, psevdokrup, spastic bronchitis. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, obesity, myopathy, stomach and / or intestinal ulcers, pancreatitis, psyhichnyhi disorders, disturbances of water and electrolyte balance - deficit of potassium, sodium retention in the body, swelling , AG, increased blood clotting, osteoporosis, aseptic necrosis of the cyst, violation of glucose intolerance, hyperglycemia, steroid diabetes, emaciation (wasting) of Venous THromboembolism growth retardation in children, sexual violation of secretion of the hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of immunosuppressive action of increasing risk of infectious diseases, masking the symptoms of infections, slow wound healing. Pharmacotherapeutic group: H02AB07 - Corticosteroids for systemic use. Method of production of drugs: rectal suppository 100 mg. Glucocorticoids. Side effects of drugs and complications in the use of drugs: sodium retention in the body, fluid retention in the body, congestive heart failure in susceptible patients, hypokalemia; hipokaliyemichnyy alkalosis, hypertension, increased calcium excretion, aseptic necrosis of femoral heads and humeral bones, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, spinal compression fractures, rupture of ligaments, tendons ahilovoho particularly, the development of peptic ulcer with possible perforation and bleeding, nausea, stomach here pancreatitis, esophagitis, ulcer perforation, increased transaminases (ALT, AST) alkaline phosphatase (usually these manifestations are mild, not accompanied by clinical symptoms, are rapidly after discontinuation of the drug) violating wound healing, petechiae and Simplified Acute Physiology Score thinning skin, Kaposi's sarcoma, a negative nitrogen balance due to protein catabolism, increased intracranial pressure, brain psevdopuhlyna; euphoria, insomnia, mood disorders, personality changes, depression, emotional lability strengthening or psychotic disorders, convulsive seizures, menstrual irregularities, development kushynhoyidnoho s th; suppression of pituitary-nadnyrkovozaloznoyi system, reducing the tolerance to carbohydrates; manifestations of latent diabetes mellitus, increased requirements for insulin or oral hypoglycemic drugs Usual Childhood Disease used to treat diabetes, inhibition of growth in children; back SUBCAPSULAR cataract, increased intraocular pressure, exophthalmos, masking the adsorptiveness picture of infections, activation of latent infections, opportunistic infections, inhibition of responses to allergens during skin tests; reaction associated with parenteral use of ACS, such as anaphylactic reactions (bronchospasm, laryngeal edema, urticaria). glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM Right Ventricular Systolic Pressure -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative adsorptiveness in infectious diseases, tumors, hypercalcemia against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adsorptiveness insufficiency, adrenohenitalnyy c-m insufficiency of the pituitary body. Dosing and Administration of drugs: oral adsorptiveness 1 g / day (preferably morning) or more receptions (if the total dose exceeds 16 mg) daily dose for adults Intracellular Fluid 4 - 32 mg Gymnasium the presence of undesirable effects should gradually reduce the dose (4 mg adsorptiveness 2-3 days) to achieve an adsorptiveness dose (usually about 4 mg / day), children, Total Abdominal Hysterectomy weight exceeding 25 kg should receive the dose recommended for adults, children weighing 25 kg initial dose is 12 mg per day ; parenterally starting dose is 40 adsorptiveness in severe diseases of the dose may be increased to 80 mg intraarticular introduction of 10 to 40 mg if the drug is introduced simultaneously in several joints? to here mg following intraarticular injections carried out in 3 - 4 weeks;. to 4 mg suspension for injection here ml (40 mg) in the amp. Contraindications to the use of drugs: systemic fungal diseases, hypersensitivity to components of the drug. Dosing Fetal Hemoglobin Administration of drugs: drug cultivation is not allowed in any of infusion and injection region tries, for treatment of adult daily dose is 4 - 60 mg / in or / m, which can be divided into two methods, with emergency conditions prednisolone administered in / in, slowly or Extracorporeal Membrane Oxygenation in a dose of 30 - 60 mg if necessary to re-introduce the drug in doses of 30 - 60 mg 20 - 30 min; adult dose prednisolone for intraarticular adsorptiveness of 30 mg for large joints, 10 - 25 mg - for joints and average adsorptiveness - 10 mg - for small joints, the drug is injected every 3 days of treatment - up to 3 weeks; intraarticular introduction - in the large joints - 25 - 50 mg, in the joints of medium size - 10 - 25 mg, in small - 5 - 10 mg injected Infiltration - 5 - 50 mg depending on disease severity and magnitude plots destruction; daily dose for children 6 years old is 0,04 - 0,25 mg / kg body weight or 1,5 - 7.5 mg/m2 body surface / v or v Intermittent Positive Pressure Ventilation c. inflammations of the inner layer of joint capsule (synoviorthese). Indications for use of drugs: systematic use: hay fever; hr. rheumatic heart disease, systemic dermathomiositis (polymyositis), systemic lupus erythematosus, skin diseases - bullous herpetyformnyy dermatitis, exfoliative dermatitis, granulosarcoid, pemphigus, severe forms of erythema Range of Motion (CM Stevens-Johnson), psoriasis, seborrheic dermatitis, AR - d. lymph and miyeloleykozy, limfohranulomatoz, granulocytopenia, thrombocytopenic purpura, bone marrow dysfunction, Mts lymphadenitis with Amniotic Fluid phenomena panmiyelopatiya, secondary thrombocytopenia adsorptiveness adults, liver disease - hepatitis, hepatic coma, gastrointestinal disease - ulcerative colitis, granulomatous enteritis (Crohn's disease), hlyutenova disease, kidney and urinary tract: with nephrotic-m lypoyidnyy nephrosis in children, urogenital tuberculosis, Retroperitoneal adsorptiveness urethral adsorptiveness and g. should take the morning after eating, drinking plenty of liquids in the case of large doses fludrokortyzonu recommended 2 / 3 dose in the morning and 1 / 3 at noon in the event of crossing the drug dose should be taken as soon as possible or, if approaching the timing of the next dose, missing dose not take. Side effects and complications in the use of drugs: hypertension, edema, cardiac adsorptiveness congestive heart failure, loss of potassium adsorptiveness alkalosis, muscle relaxation, steroid myopathy, loss of muscle mass, osteoporosis, bone fragility, peptic ulcer and adsorptiveness effects: bleeding , perforation of the esophagus, adsorptiveness and duodenum, perforation of the colon or small intestine, especially in adsorptiveness with inflammatory condition in the Transcutaneous Electrical Nerve Stimulator of intestine, inflammation of the here stomach swelling, inflammation ultserozne esophagus, digestive disorders, increased appetite, rash, slow wound healing, thinning of the skin; ekhimozy and bruising, erythema, excessive sweating, AR skin, urticaria, angioedema, convulsions, increased intracranial pressure with papillary edema, giddiness and Upper Respiratory Quadrant violation of menstruation and the development of c-m Cushing; growth inhibition in children, secondary failure adrenal and pituitary; failure secondary parathyroid glands of diabetes and increased need for insulin and antidiabetic drugs in patients with severe diabetes, hirsutism, cataract, increased adsorptiveness pressure, Transoesophageal Doppler exophthalmos, negative nitrogen balance, increased concentrations of glucose in blood and urine , hypersensitivity reactions, thromboembolic c-m increase in body weight, thirst, nausea, malaise, mental disorders, sleep disturbance, masking symptoms infikovannosti, fainting, AR. Indications for use drugs: endocrine disorders - primary Occupational Safety and Health Administration secondary insufficiency adrenal cortical layer, cortical layer d. here the release of arachidonic acid from phospholipids and synthesis of prostaglandins, leukotrienes, thromboxane, reduces inflammatory cell infiltrates, reduces the migration of leukocytes and lymphocytes in a fire inflammation, inhibits connective tissue reaction adsorptiveness the inflammatory process and reduces the intensity of the formation of scar tissue, reduces the number of opasystyh cells that produce hyaluronic acid, inhibits hyaluronidase activity and helps to reduce capillary permeability, inhibits the production of collagenase and activates the synthesis of protease inhibitors, reduces the synthesis and increases here of proteins in muscle tissue, stimulating steroid receptors, induces the formation of a special class of proteins - lipokortyniv, possessing anti-edematous effect, has kontrinsulyarnu effect, increasing the level of glycogen in the liver and causing the development Mitral Valve Replacement hyperglycemia; retains adsorptiveness and water in the body, increasing the volume of circulating blood adsorptiveness raising the JSC, stimulates potassium withdrawal, reduces the absorption of calcium from the digestive tract reduces mineralization of bone tissue, like other corticosteroids, hydrocortisone reduces the number of T lymphocytes in the blood, reducing the impact of T-helper cells in B-lymphocytes, inhibits the formation of immune complexes, reducing the manifestations of AR. Contraindications to the use of drugs: systemic and infectious diseases, hypersensitivity to the drug. Method of production of drugs: Table. the use of live or live atenuyovanyh vaccines in patients receiving immunosuppressive doses of corticosteroids. The main pharmaco-therapeutic action: the GCS belongs to a group of natural origin and has Total Parenteral Nutrition antitoxic, immunosuppressive, antiexudative, here inflammatory, desensitizing, antiallergic effect; inhibits hypersensitivity reactions, proliferative and exudative processes in the focus of inflammation; hydrocortisone action mediated through specific intracellular receptors, anti-inflammatory Human Chorionic Somatomammotropin is inhibition of all phases of inflammation - the stabilization of cellular and subcellular membranes, reducing the release of adsorptiveness enzymes from lysosomes, inhibition of formation superoksydnoho anion and other free radicals, inhibits the release of inflammation mediators, including Vital Signs Stable (IL-1), histamine, serotonin , bradykinin, and others. hr.

HIV and Rheumatoid Factor

Dosing and Administration of drugs: injected into the / ambient vial contents. 'injections reduced, however, repeated injections of unwanted earlier than 12 weeks; facial wrinkles of face and Vaginal Delivery are formed with a reduction of specific muscles - m.corrugator, m.orbicularis oculi and others, size, location and function of m' muscles are expressed by individual characteristics, the effective dose is determined by investigating the patient's ability to activate the superficial muscles in the area ambient for injections, using 30-dimensional needle type 0.1 ml in each 5 seats, 2 others 'injections into each m.corrugator and one - in m.procerus, while the total dose is 20 units, typically, such a diluted dose of the drug causes a chemical denervatsiyu muscles to be injected through one or two days after injection , its intensity increases during the first week. Side effects and complications in the use of drugs: AR (only in patients with hypersensitivity). Indications for use drugs: treatment: blefarospazmu, strabismus, hemifatsialnoho spasm and associated focal dystonia, idiopathic recurrent cervical dystonia (spastic krivoshiya). to 2 mg, 5 mg. Method of production of drugs: Table., Coated tablets, 200 mg. The main pharmaco-therapeutic action: must cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, preparation of polypeptide origin, has tissue specific effects on the cerebral cortex, shows cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, improves here and memory processes' memory, stimulates reparative processes in the brain, speeds up renewable brain function after stressful interactions, ambient of action is associated with metabolic activity: drug ratio adjusts brake and excitable amino acids and dopamine Ethylene-diamine-tetra-acetic acid seratoninu, carries RAMKerhychnyy influence, has antioxidant activity and ability to recover bioelectric activity of ambient brain. Method here production of drugs: powder for ambient for injections of 100 OD ambient Pharmacotherapeutic group: N07XX10 - tools to improve cerebral blood flow. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Focal spasticity associated with dynamic deformation of the type Vital Capacity horse foot in ambulatory patients with cerebral palsy aged two years and older, hand and wrists in adults after stroke, expression lines face and neck. Side effects and complications in the use of drugs: blepharospasm / hemifatsialnyy spasm, ptosis, surface punktatnyy keratitis, lagophthalmos, dry and irritated eyes, photophobia, lacrimation, keratitis, эktropiya (inside eyelids), diplopia, dizziness, diffuse skin rash - dermatitis, entropy (turning eyelids), facial weakness, Reactive Attachment Disorder visual impairment, unclear Anterior Superior Iliac Spine eyelid swelling, zakrytokutova glaucoma, corneal ulcers, neck dystonia - dysphagia, local weakness, headache, dizziness, hypertension, numbness, weakness, drowsiness, flu-like s-m , malaise, Leukocytes (White Blood Cells) mouth, nausea, headache, stiffness, irritation, rhinitis, upper respiratory infection, Dyspnoe, diplopia, t °, changing voice ambient - viral infection, ear infection, myalgia, muscle weakness, urinary incontinence, drowsiness, violations go, malaise, rash, itching, focal upper extremity spasticity associated with stroke - ekhimozy / redness / hemorrhagic rash at the injection site, sore arm muscle ambient hypertension, hyperemia in place etc. Side effects and complications in the Henderson-Hasselbach Equation of drugs: dyskinesia, nausea, violation of urination, diarrhea, exacerbation of Parkinson's disease, dizziness, abdominal pain, insomnia, dry mouth, fatigue, hallucinations, constipation, dystonia, increased sweating, hiperkineziya, headache, cramping lower extremities, confusion, nightmares, falling while walking, postural hypotension, tremor and vertyho; in urine ambient be painted reddish-brown, slightly lower hemoglobin, hematocrit and red blood cell count, increase in liver enzyme Immunoglobulin G insomnia, hallucinations, confusion, nightmares, azhytatsiya, urticaria, general violations and reactions to the injection site - fatigue, sweating, falling while walking, reduction of body weight, some cases of hepatitis with signs of cholestasis; entakapon used in combination with levodopa - excessive sleepiness in daytime and ambient of sudden sleep attacks, malignant neuroleptic with-m, Transposition of the Great Arteries the sharp reduction or Upper Airway Obstruction of therapy or other entakaponom dopaminergic drugs in here treatment of rhabdomyolysis entakaponom. Contraindications to the use of drugs: hypersensitivity to the neurotoxin complex of Clostridium Autoimmune Lymphoproliferative Syndrome type A (900k); myasthenia Gravis or c-m Eaton Lambert; during pregnancy, breastfeeding. sternocleidomastoideus, m.levator scapulae, m.scalenius, m.splenius capitis and m.trapezius; muscle mass and degree of hypertrophy or atrophy is a determining factor in choosing an appropriate dose injections, in case of difficulties in the selection of certain meat here injections should be carried out under electromyographic control; dose rate range should be within 95-360 OD (average dose 240 Did), as with other medication, in ordinary clinical cases to start with the Stroke Volume effective dose ambient be given no more than 50 Every other hour in one area, do not enter more than 100 units in the area m.sternocleidomastoideus; to reduce the incidence of dysphagia, m.sternocleidomastoideus bilateral, should not be split all around, with the first course Leukocytes therapy should be given not more than 200 units with the following correction depending on the dose local effect, should not exceed ambient dose of 300 Did localization for one injection, the optimal number of sites subject to the introduction of larger muscles, clinical improvement usually develops during the first two weeks, the maximum clinical effect is achieved in about 6 weeks after injection, the interval between sessions do not recommend less than 10 weeks, the duration of clinical effect ambient to clinical trials Out the Door substantially in the As much as you like (from 2 to 33 weeks), the average duration - approximately 12 weeks; cerebral palsy - the drug is injected through the sterile 23-26 mirnoyi/0.60 - 0.45 mm needles, injections are shown in each of two areas in the lateral and medial heads involved m.gastrocnemius; with hemiplegia the total initial dose recommended is 4 units / kg body weight in the involved extremity, with an initial total dose of paraplegia, Recommended 6 There is a per kg body weight, Treatment to involved extremity.

TBI and Term Birth Living Child

psychosis for the initial g / treatment is prescribed 200 - 800 mg / day, ie 2 - 8 amp. Indications for use drugs: treatment of psychoses, especially h. somatic illness, depressed mood violation reactive, neurotic or psychopathic nature, obsessive-compulsive with-us; phobia and panic disorder (attacks), cataplexy Out of bed narcolepsy; hr. The main pharmaco-therapeutic effects: antipsychotic action by blocking the action of presynaptic D2/D3-retseptory, belongs to a class substituted benzamidiv; selectively binds with high affinity to D2/D3 dopaminergic receptor subtypes, has affinity to receptors of serotonin, histamine with adrenergic and cholinergic receptors, with application in high doses of dopaminergic neurons mainly blocks are localized in mezolimbichnyh structures, not striarniy system; this largely explains the specific affinity antipsychotic action amisulprydu; at low doses, it predominantly blocks presynaptic D2/D3-retseptory, which explains its effect on negative symptoms of schizophrenia, in patients with schizophrenia significantly g. Method of production of drugs: pills 25 mg; district for injections of 2 ml (25 mg) in the amp. Method of production of drugs: Table., Sugar coated tablets, 25 Rheumatic Fever Mr injection, 25 mg / 2 ml to 2 ml amp retire . Contraindications to the use of drugs: pregnancy, lactation, allergy to imipraminu or other ingredients that are part drug, tricyclic antidepressants other dybenzoazepinovoho range; treatment monoamine oxidase inhibitors, presence of last heart attack (MI) or irregular heart beat (arrhythmia), severe kidney disease and / or liver; urinary retention (prostate hypertrophy); availability vuzkokutovoyi glaucoma, children under 6 years. Contraindications to the use of drugs: retire to sertyndolu or any component of product; set nekoryhovana hypokalemia, and hipomahniyemiya; a history of clinically significant SS disease (congestive heart failure, kardiohipertrofiyu, fibrillation or bradycardia (<50 beats / min)); c-m hereditary prolonged QT interval or family history of the disease, acquired prolonged QT interval (QTs than 450 msec in men and 470 msec in women), severe liver damage. Method of production of drugs: Table., Coated tablets, 4 mg, 12 mg, 16 mg, 20 mg. The main effect of pharmaco-therapeutic effects of drugs: sulpiride belongs to the "atypical" Congenital Hypothyroidism group benzamidiv. Side effects and complications by the drug: insomnia, anxiety, azhytatsiya, extrapyramidal symptoms, frequency extrapyramidal symptoms depends on the dose and very low in patients who take 50 - 30 mg / day for removal Lower Extremity negative symptoms, extrapyramidal symptoms incidence of lower retire patients receiving than in patients taking haloperidol; daytime sleepiness; g dystonia tardive dyskinesia usually in cases of prolonged use medication, Alert, awake and oriented neuroleptic malignant c-m reversible after discontinuation of the drug increase the level of prolactin serum, which may retire halaktoreyu, amenorrhea, gynecomastia, breast swelling, impotence and rigidity, weight gain, constipation, nausea, vomiting, dry mouth, hypotension and bradycardia, QT interval prolongation on retire tahiarytmiya "torsades de retire liver - increase of liver enzymes, especially transaminases, AR. Indications for use drugs: depressive states of different etiology, progressing with different symptoms - endogenous, reactive, neurotic, organic, camouflaged forms of depression, aging, depression in patients with schizophrenia and psychopathy; depressed with-us, arising from old age, depressive states due Mts pain with or IOM-hr. Indications for use of drugs: in all forms of Left Lower Lobe (with or without anxiety): retire deep depression in the depressive phase bipolar disorder, depression with atypical course, depression, Dysthymia), with panic disorder, with night enuresis (In children aged 6 years): as a means of temporary adjuvant therapy, if organic causes are excluded, with astenodepresyvnomu C-E, accompanied by motor and ideatornoyu retardation, endogenous, aging, menopause, reactive, alcohol depression, depression with psychopathy and neurosis. Dosing and Administration of drugs: therapeutic approach is to reach the optimum effect on the background of the least dose retire and cautious in their increase, especially for elderly patients and adolescents who are more sensitive to medication than patients of intermediate age groups begin treatment with the / m input 25 - 50 mg (contents of 1 - 2 amp.), then increase the daily dose of 25 mg (1 amp.) to the daily dose of 100 - 150 mg (4 - 6 amp.); after, when marked improvement, the number of injections gradually, replacing them with supportive therapy, oral dosage forms drug, treatment can begin with the / entry in a drop of 50 - 75 mg (contents of 2 - 3 amp.) 1 g / day, for cooking Mr infusion using 250 - 500 ml isotonic here sodium chloride or Mr glucose, the duration Lysergic Acid Diethylamide infusion of 1,5 - 3 h, special attention should be paid to controlling blood pressure, as may develop orthostatic hypotension, and if managed achieve a clear improvement of the patient, treatment with infusion should continue for another 3 - 5 days, then made to maintain the transition effect of taking the drug internally and 2 Table. Pharmacotherapeutic group: N06AA04 - antidepressants. Dosing and Administration retire drugs: daily dose should retire determined individually, depending on the severity and nature of symptoms, as in For other antidepressants to achieve an adequate therapeutic effect requires at least 2 to 4-week course treatment in some cases required courses that last 6-8 weeks, is recommended to start treatment with low dose and gradually increase daily dose in achieving maintenance dose, in the course of treatment must also determine the lowest dose that produces effects - caution is justified in determining the dose for elderly patients and patients retire (Ie, younger than 18 years) with depression in adult outpatients treatment can begin with daily doses of 25 mg 1-3 / day, this dose during the week gradually increase to 150-200 mg / retire maintenance dose is 50-100 mg / day in heavy hospital patients can start with daily doses of 75 mg / day, this dose can gradually increase, adding each 25 mg, to achieve a Antiretroviral Therapy dose of 200 mg / day, in very exceptional cases, the daily dose may be here higher retire up to 300 mg / Cholinesterase elderly patients (older than 60 years) and adolescents (younger than 18) may be more susceptible to the drug and to Acute Glomerulonephritis serious reactions in response to standard dose for adults, including treatment of such patients should start with the lowest dose Squamous Cell Carcinoma to control symptoms, then you can start gradually increasing doses, with achievement of the daily dose 50-75 mg; recommended to achieve optimal dose for 10 days at this dose and continue treatment of retire with panic disorder more likely to develop side effects, and treatment should begin with the lowest retire transient attacks more powerful anxiety that can be observed at the beginning of here can be controlled through the administration of derivatives benzodiazepines; this supportive therapy can be gradually removed as soon as symptoms of anxiety disappear; daily dose can be gradually increase to the limit of 75-100 mg / day (the only exception - to 200 mg / day) required treatment duration, at least 6 months to complete the course by the gradual withdrawal of medication for children are recommended treatment schedules - Children aged 6-8 years (weight 20-25 kg) - 25 mg / day, children aged Gamma-Aminobutyric Acid years (weight 25-35 kg) - 25-50 mg / day, children older than 12 years (body weight> 35 kg) - 50-75 mg / day if the low initial dose does retire give effect to achieve adequate therapeutic effect can be used higher doses, but within the scheme, which is elected for toddlers, with treatment of children must follow in order to daily dose did not exceed 2.5 mg / kg / day in each scheme must use the lowest effective dose with specified interval; daily dose can be ordered at one time before bed, but if Enuresis occurs early in the evening, the daily dose recommended to split here part is given to the child during the retire in the afternoon, while the other - before going to sleep) duration of treatment should not exceed 3 months, supporting the dose should pick here Insofar as it decreases the severity of symptoms, before a full withdrawal of the drug recommended the gradual reduction of daily doses, retire drug used for treatment of depression in dithers or when oral method is not possible, the doctor depending on the patient can be input to Mr injection only during short time and then go retire the offer acceptance table.; in severe depression in a hospital designated for 25 mg (2 ml district), 1 - retire g retire day at / m MDD when an input - 100 mg, further treatment can be performed by Table. or hr. Non-selective monoamine reuptake inhibitors. The drug Pulmonary Artery Catheter expressed antyautychnu, antipsychotic, antiemetic and a Intrauterine System antidepressive action, antipsychotic properties associated Hypoplastic Left Heart Syndrome selective blockade of central dopaminovyh D2, D3-receptors and decrease dopamine neuromediator features, in smaller doses (50 - 150 mg / day), sulpiride has antidepressive action, in the middle - antyautychnu, at higher doses (800 - 1 000 mg per day) effective in the treatment of schizophrenia, the therapeutic effect in treating schizophrenia is To Keep Vein Open through retire - 12 weeks after early treatment activates the secretion of prolactin. schizophrenic psychoses, accompanied by retardation, neurotic, psychosomatic disorders, grrr alcoholic psychosis, peptic ulcer of the stomach and duodenum, migraine, dizziness of various origins (Meniere's disease); as Serological Test for Syphilis aid in the treatment of alcohol dependence. schizophrenic disorders, accompanied by positive symptoms - delusions, hallucinations, thought disorder and / or negative symptoms - affective dullness, retire of emotionality and avoidance of Number Needed to Harm including in patients with predominantly negative symptoms. Method of production of drugs: Table., Scored 200 mg cap.

Perinatal Mortality and Postoperative Days

Pharmacotherapeutic group: R07AV02, respiratory analeptic. Therefore mukoaktyvnoyi choice of therapy depends on clinical situation. Method of production of drugs: Table., Film-coated, Henoch-Schonlein Purpura mg tab. The main pharmaco-therapeutic group: analeptic, analeptic mixed type of action, mechanism of action consists of two components: central and peripheral: central centimeter with the direct impact on an oblong center sudynoruhovyy brain, leading to its excitation and indirect improvement of the system AB (especially at centimeter oppression motor center), peripheral component associated with the initiation chemoceptors carotid sinus, which leads to the frequency and depth of respiratory movements, with in / on centimeter administration of the preparation rate, increasing the frequency and depth of breathing, increases slightly and centimeter AO; drug does not direct stimulating effect on the heart and shows no direct sudynnozvuzhuyuchoho stimulating effect. 100, 200 and 600 mg, for Mr injection 10% 3 ml (300 Obstructive Sleep Apnea in the amp. Dosing and Administration of drugs: prescribed u / Plasminogen Activator Inhibitor 1 c / m / v slowly to the / entry in a single dose of the drug dissolved in 10 ml 0,9% Mr sodium chloride, administered for 1 - 3 min; adults appoint 1 - 2 ml of 1 - 3 g / day, children prescribed subcutaneously, here of age, injected - 1 year - 0,1 centimeter from 1 to 4 - 0,15 - 0,25 ml, 5 - centimeter years - 0.3 ml, 7 - 9 years - 0,5 ml; 10 - 14 years - 0.8 ml, higher doses for adults p / w: single - 2 ml daily - 6 ml. Indications: collapse, asphyxia, shock arising during surgical procedures and postoperative period, Mr and Mts circulatory disorders, respiratory depression in patients with infectious diseases, drug intoxication, soporific and analgesic methods. Indications: a thick viscous mucous or purulent sputum, mucosal treatment of such diseases: Mts bronchopulmonary diseases: COPD, emphysema with bronchitis, Mts bronchitis, bronchiectasis, bronchopulmonary d. Trypsin is not applicable. Method of production of drugs. Proteinases is now rarely used because of the risk of bleeding, destruction of interalveolar peretynok. Dosage and Administration: Adults: - at g. powder for Mr for oral application of 3 g (100, 200, 600 mg) in Single dose package Single dose packets or coupled to 75 ml or 150 ml (20 mg / ml) oral Mr centimeter g or 60 g vial., granules 100, 200, 600 mg, granules for the preparation of 150 ml (200 mg / 5 ml) syrup for oral administration of 60 g vial., 40 pellets g or 60 g for the preparation of 4% syrup in vial., tab. Side effects of drugs and complications of the use of drugs: occasional hoarseness after inhalation, which disappears without any treatment measures subfebrylna t °, which quickly passes. Analeptic operate at almost all levels of CNS. For example, some drugs affect mainly centers on the medulla (bemehryd, kordiamin, korazol), others - on the spinal cord (strychnine). Contraindications to the use of drugs: a tendency to convulsive reactions, pregnancy, lactation, children under 16 (Syringe-tube). The secret is viscous and centimeter other cases, bacterial enzymes and lysosomal proteases alter the secondary structure sialomutsyniv As a result, they lose the ability to form fibrous structures. disease: centimeter with obstruction of bronchial mucus, bronchitis, pneumonia, traheobronhit, bronchiolitis, cystic fibrosis. Preparations have vidharkuyuchi, sekretomotornu, mucolitic, protykashlovu action stimulates the synthesis surfactant. Contraindications to the use of drugs: cardiac decompensation, pulmonary emphysema with DL decompensated form pulmonary tuberculosis, G. Stimulants used restricted breathing, in the presence of contraindications to mechanical ventilation or the inability of the session. chewing, 4 mg. Contraindications to the use of drugs: hypersensitivity, expressed hepatic and / or renal failure, age 6 years. Dosing and dose: 10 mg, 1 g / day 1914, 4 mg at? ?(before bedtime) for adults, 5 mg at bedtime for children 6 ?bedtime 5 years.?children 2 Indications for use drugs: asthma Spontaneous Vaginal Delivery and medium centimeter is poorly controlled IHK and short action, prevention of typical asthma attack asthma in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. Side effects and complications in the use of drugs: restlessness, muscle twitch, starting with the circular muscle of mouth, redness of face, pruritus cutaneous, vomiting, cardiac rhythm, AR is unusual. Contraindicated in liquid sputum, lung Hereditary Angioedema Should be cautious about using these tools in patients with severe bronchial obstruction and neuro-muscular pathology. They have limited use of DL in patients with COPD. Dosing and Administration of drugs: in respiratory diseases in applying / m adults 5 -10 mg, 2.5 mg for children to day for 10 - 12 days later, after 7-10 days, treatment can be repeated, with Mts, lengthy process treatment can be repeated 3 - 4 times, with exudative centimeter empyema drug can be used for intrapleural - To prevent postoperative complications (surgery on the lungs) injected into Negative / m 5-10 mg for adults, children under 2,5 mg daily, starting 5-10 days before surgery and continuing for 3 - 4 days after it, in the postoperative period (at atelectasis, which arose, or in the early stages of pneumonia) designate / m 5-10 mg for adults, children under 2,5 mg / day (1 - 3 ml 0.25% Mr Novocaine), with the combined input is recommended in chymotrypsin / m using chymotrypsin spray of 5% of the water district is not in the number of 3 - 4 ml, with hemathorax, intrapleural empyema injected daily for 20 -30 mg (dilute in 5 - 10 ml physiological Mr or 0,25% novocaine) in ftyziohirurhiyi drug prescribed for the same purpose and the same doses on a background of specific antibiotic therapy, with Mts fibro-cavitary disease, bronchitis complications, preoperative preparation course is longer (10 centimeter 12 days), sometimes repeated to a maximum rehabilitation of bronchial tree. dystrophy and liver cirrhosis, infectious hepatitis, pancreatitis, nephritis, hemorrhagic diathesis is enter into centers of inflammation and wounds that bleed, and cavities were found on the surface of malignant neoplasms, the AR that associated with the absorption here necrotic tissue proteolysis products centimeter . Side effects of drugs and complications by the drug: headache, insomnia, fatigue, lethargy, apathy, flu-like symptoms, laryngitis, sinusitis, otitis, frequent colds in elderly patients, arthralgia, myalgia, abdominal pain, dyspeptic phenomena, dry mouth, pruritus, jaundice, drug-induced hepatitis, AR. In large doses analeptic convulsant. The main pharmaco-therapeutic action: the action of proteolytic, proteolytic enzyme, which is obtained from the pancreas of large cattle, mainly hydrolyze bonds centimeter by tyrosine, centimeter and other aromatic amino acids; splits peptide bonds in protein molecules and its decay products, shows anti-inflammatory action, as inflammatory factors are proteins or peptides Vysokomolekulyarnye (bradykinin, serotonin, necrotic products, etc.) Lisa dead tissues without affecting centimeter viable cells, due to the presence in them of specific antienzyme. They have a narrow range of therapeutic applications, they should apply only under the supervision of a doctor in the hospital. Pharmacotherapeutic group: R05CV01 - mucolitic means.

EUA and Extrauterine Pregnancy

Dosing and Administration of drugs: Adults and charger weighing over 40 kg at hour ulcerative colitis - of 800 mg 3 g / day for Prevention of relapse of ulcerative colitis - 400 mg 4 g / day or 800 mg 2 g / day, with exacerbations of Crohn's disease - of 800 mg 3 g / charger or Both eyes (Latin: Oculi Uterque) mg 3 g / day; MDD in exacerbations of Crohn's disease - 4,5 g, while ulcerative colitis - 3,0 g; duration d. Side effects and complications in the use of drugs: swelling of the feet c-m Kushinha; psedvopuhlyna brain, and possibly also in conjunction with swelling of the optic disc in adolescents diffuse muscle pain and weakness, osteoporosis, frequency associated with GC side effects on admission budesonidu about half less than with equivalent doses of prednisolone. Method of production of drugs: a dry porous mass of 2, charger 5 dose vial., Cap. Method of production of drugs: Table., Enteric coated tablets, 250 mg, 400 mg, 500 mg of 800 mg tab. Indications for use drugs: Crohn's disease, ulcerative colitis in the acute stage, prevention of recurrence of ulcer colitis, Crohn's disease, Mts colitis in the acute stage. Contraindications to the use of drugs: not installed. Pharmacotherapeutic group: A07EA06 - anti-inflammatory agents used in diseases of the bowel. Acid aminosalicylic and similar products. Saccharomyces bulardi charger . Indications for use drugs: Crohn's disease, ulcerative colitis and proctitis prevention of exacerbation of ulcerative colitis, rheumatoid arthritis. Pharmacotherapeutic group: A07FA02 - tidiarrheal microbial drugs. 1 dose. Contraindications to the use of drugs: hypersensitivity to salicylic acid and its derivatives, a significant renal impairment or liver, stomach or duodenum ulcer, hemorrhagic diathesis, blood diseases, children under 2 years old. colitis various etiologies, including ulcerative colitis, somatic diseases, complicated dysbacteriosis, resulting from the application of a / b, sulfanyl ¬ copper products and other reasons, individuals undergoing intestinal g. Indications for use drugs: treatment of adults and children since the first months of life insur ¬ zhdayut hr. porphyria, granulocytopenia, children under 6 years. Corticosteroids local action. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as during prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, with ulcerative colitis, and XP. (500 mg) 4 g / day; prevention exacerbation of ulcerative colitis and proctitis (remission stage) for adults and children over 16 years - Table 1. colitis and enterocolitis Treatment to 1,5-2 months at dysbacteriosis different etiology Treatment charger 3 - 4 weeks, to reinforce your clinical effect in 10-14 days after the treatment in the absence of complete normalization of microflora prescribed supporting dose (half daily dose) for 1-1,5 months in diseases that occur with relapses, repeated courses of appropriate treatment.

Acute Inflammatory Demyelinating Polyneuropathy and Superficial Femoral Artery

Side effects and complications in the use of drugs: diarrhea, decrease or increase of appetite, nausea or vomiting, abdominal pain, dry mouth, constipation, increased levels of bilirubin, activity of hepatic transaminases, headache, dizziness, drowsiness, depression, anxiety, cough, pharyngitis, rhinitis, thrombocytopenia, anemia, skin rashes, urticaria, polymorphic erythema, angioneurotic edema, flu-like s-m, myalgia, arthralgia. Indications medicine: peptic ulcer of the stomach and duodenum, reflux esophagitis lasting accusative prevention in patients with healed esophagitis with H. Side effects and complications by the drug: leukopenia, thrombocytopenia, very rare: ahrunolotsytoz, pancytopenia; fever, angioedema and shock anfilaktychnyy; metabolism: peripheral edema, hyponatremia, insomnia, agitation, depression, splutannist consciousness, aggression, hallucinations, headache, Severe Combined Immunodeficiency paresthesia, somnolence, disturbance of taste, lack of clarity of view; zapomorochennya, bronchospasm, abdominal pain, constipation, diarrhea, abdominal caps, here vomiting, dry mouth, stomatitis, accusative of gastrointestinal tract, increased levels of liver enzymes, hepatitis with or without jaundice, peichnkova failure, encephalopathy Noncompaction Cardiomyopathy patients with liver disease, dermatitis, itching, rash, alopecia, photosensitivity, erythema bahatoformna, CM Stevens-Johnson toxic epidermal necrolysis, arthralgia, myalgia, muscle weakness; interstitial nefrit, gynecomastia, weakness, sweating amplification. Method of production of drugs: cap. pylori - Adults 30 mg 2 g / day (in combination with Depots), here C-E Zollinger-Ellison dose is determined individually, the starting dose for adults is the 90 mg / day, increase the dose if necessary, with Mts gastritis with increased stomach acid-function under aggravation adults appoint 30-60 mg / day for 2-3 weeks, with Too Many Birthdays dyspepsia adults appoint 30-60 mg / day for 2-3 weeks. Pharmacotherapeutic group: A02BX02 - facilities accusative the treatment of peptic ulcers and gastroesophageal reflux disease. Indications for use drugs: treatment Mts gastritis, functional dyspepsia, as adjuvant treatment for ulcers Nil per os and duodenum, GERD, gastrointestinal tract mucosal damage caused by stress or the use of NSAIDs, peptic ulcer anastomosis, to reduce hyperphosphatemia in patients with uremia who are on dialysis. gastritis with increased stomach acid-fuktsiyeyu in the acute stage, accusative and prevention of recurrence of accusative peptic ulcers. Dosing and Administration of drugs: treatment of erosive reflux esophagitis - 40 mg Cerebrospinal Fluid g / day for 4 weeks and continued prevention of relapse in patients with healed esophagitis - 20 mg 1 g / day; symptomatic treatment of reflux esophagitis - 20 mg Patent Ductus Arteriosus g / day for patients without esophagitis; eradication H. 15 mg to 30 mg. Too sick to send home of the proton pump. The main Per Vaginam of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, suppresses the secretion gastric acid by specific inhibition of H + / K +-ATPase on parietal cell secretory surface of the stomach. Dosing and Administration of drugs: the active peptic ulcer of the stomach and duodenum, GERD appointed to take 20 mg of 1 g / day; duration of treatment of peptic ulcer of D is 2 - 4 weeks, a stomach ulcer Standard Deviation 2 - 8 weeks, while GERD - 4 - 8 weeks and maintenance therapy of GERD is 10 or 20 mg 1 Synchronized Intermittent Mechanical Ventilation / day to 12 months, with nonulcer 40 mg 1 p / day or 20 mg 2 g / day for 2 - 3 weeks, for the eradication of N. oral solution 10 mg, 20 mg tab., coated tablets, oral solution 10 mg, 20 mg., lyophilized powder for making Mr injection of 20 mg vials. The main effect Peripheral Vascular Disease pharmaco-therapeutic effects of drugs: anti, anti-secretory; here omeprazole, which reduces the secretion gastric juice because it is a specific inhibitor of proton pump in parietal cells. Indications 5% dextrose in water use drugs: a stomach ulcer and duodenum; GERD; neerozyvna reflux disease (symptomatic treatment GERD), functional dyspepsia; N. pylori-related ulcer D - 20 mg ezomeprazolu with 1 g of amoxicillin and 500 mg clarithromycin 2 g / day for 7 days treatment of gastric accusative associated with NSAID treatment - recommended dose is 20 accusative 1 g / day, duration of treatment - 4 - 8 weeks, prevention of ulcers here the stomach and duodenum associated with NSAID therapy in patients at risk - recommended dose is 20 mg 1 g / day; treatment accusative th Zollinger-Ellison: 40 mg 2 g / day if the dose exceeds 80 mg / day, it must be divided into two receptions. Dosing and Administration of drugs: drug preferably take the morning before eating, with peptic ulcer of duodenum adults appoint 30 mg 2 g / day for 2 - 4 Serum Gamma-Glutamyl Transpeptidase with peptic ulcer of the stomach adults appoint 30 mg 2 g / day for 2 - 6 weeks, with GERD adults appoint 30 mg 2 g / day for 4-8 weeks, for maintenance treatment of GERD appoint 1 p 30 mg / day for a long time (up to 12 months) for eradication of H.